A new Chinese hamster ovary cell line expressing alpha2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins.

Chinese hamster ovary (CHO) cells are widely employed to produce glycosylated recombinant proteins. Our group as well as others have demonstrated that the sialylation defect of CHO cells can be corrected by transfecting the alpha2,6-sialyltransferase (alpha2,6-ST) cDNA. Glycoproteins produced by such CHO cells display both alpha2,6- and alpha2,3-linked terminal sialic acid residues, similar to human glycoproteins. Here, we have established a CHO cell line stably expressing alpha2,6-ST, providing a universal host for further transfections of human genes. Several relevant parameters of the universal host cell line were studied, demonstrating that the alpha2,6-ST transgene was stably integrated into the CHO cell genome, that transgene expression was stable in the absence of selective pressure, that the recombinant sialyltransferase was correctly localized in the Golgi and, finally, that the bioreactor growth parameters of the universal host were comparable to those of the parental cell line. A second step consisted in the stable transfection into the universal host of cDNAs for human glycoproteins of therapeutic interest, i.e. interferon-gamma and the tissue inhibitor of metalloproteinases-1. Interferon-gamma purified from the universal host carried 40.4% alpha2,6- and 59.6% alpha2,3-sialic acid residues and showed improved pharmacokinetics in clearance studies when compared to interferon-gamma produced by normal CHO cells.

[1]  N Jenkins,et al.  Glycosylation of recombinant proteins: problems and prospects. , 1994, Enzyme and microbial technology.

[2]  R. Pagano,et al.  Molecular trapping of a fluorescent ceramide analogue at the Golgi apparatus of fixed cells: interaction with endogenous lipids provides a trans-Golgi marker for both light and electron microscopy , 1989, The Journal of cell biology.

[3]  P. Herrlich,et al.  Interferon-gamma, mitomycin C, and cycloheximide as regulatory agents of MHC class II-associated invariant chain expression. , 1986, Journal of immunology.

[4]  J. Bailey,et al.  Tissue Plasminogen Activator Coexpressed in Chinese Hamster Ovary Cells with α(2,6)‐Sialyltransferase Contains NeuAcα(2,6)Galβ(1,4)Gl‐N‐AcR Linkages , 1995, Biotechnology progress.

[5]  O. Kon,et al.  Stable expression of human alpha-2,6-sialyltransferase in Chinese hamster ovary cells: functional consequences for human erythropoietin expression and bioactivity. , 1998, Biochimica et biophysica acta.

[6]  E. Berger,et al.  Double immunofluorescent staining of α2,6 sialyltransferase and β1,4 galactosyltransferase in monensin‐treated cells: Evidence for different Golgi compartments? , 1993 .

[7]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[8]  S. Latt,et al.  Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells , 1985, Molecular and cellular biology.

[9]  David F. Smith,et al.  A solid-phase assay for the activity of CMPNeuAc:Gal β1-4GlcNAc-R α-2,6-sialyltransferase , 1992 .

[10]  S. Tsuji,et al.  Molecular cloning and functional analysis of sialyltransferases. , 1996, Journal of biochemistry.

[11]  J. Lofgren,et al.  Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins , 1999, Nature Biotechnology.

[12]  J. Paulson,et al.  Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase. , 1989, The Journal of biological chemistry.

[13]  L. Sollid,et al.  Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells. , 1998, Gastroenterology.

[14]  L. Monaco,et al.  Expression of recombinant human granulocyte colony-stimulating factor in CHO dhfr- cells: new insights into the in vitro amplification expression system. , 1996, Gene.

[15]  H. Lodish.  Recognition of complex oligosaccharides by the multi-subunit asialoglycoprotein receptor. , 1991, Trends in biochemical sciences.

[16]  E. Berger,et al.  Comparative localization of mannose-6-phosphate receptor with 2,6sialyltransferase in HepG2 cells: an analysis by confocal double immunofluorescence microscopy. , 1995, European journal of cell biology.

[17]  R. Pagano,et al.  A vital stain for the Golgi apparatus. , 1985, Science.

[18]  J. Paulson,et al.  Demonstration of an extensive trans-tubular network continuous with the Golgi apparatus stack that may function in glycosylation , 1985, Cell.

[19]  M. Uhlén,et al.  An in vitro amplification approach for the expression of recombinant proteins in mammalian cells , 1994, Biotechnology and applied biochemistry.

[20]  K. Sato,et al.  A specific DNA sequence controls termination of transcription in the gastrin gene , 1986, Molecular and cellular biology.

[21]  M. Fukuda,et al.  Expression cloning of glycosyltransferases. , 1996, Glycobiology.

[22]  D. James,et al.  Posttranslational processing of recombinant human interferon‐γ in animal expression systems , 1996, Protein science : a publication of the Protein Society.

[23]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[24]  A. Bull,et al.  N‐glycans of recombinant human interferon‐γ change during batch culture of chinese hamster ovary cells , 1995 .

[25]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[26]  P. Stephens,et al.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.